Location: Gandimisamma Cross Roads, Hyderabad area

Built-up area: over 300,000 sq.ft.

The Company's world-class and world-scale facilities for injectibles set up in collaboration with Vetter group, Germany was designed and Master planned by Magal Associates. It has been a USFDA registered facility since 2003. The technological edge in injectibles and specially Pre-filled syringes is due to a research focused approach continuously developing niche products for Indian and global Pharmaceutical markets. Gland Pharma has pioneered Heparin technology in India and has a position of leadership in the Glyco Amino Glycans (GAGS) range of molecules. The company manufacturers Active Pharmaceutical Ingredients (APIS) and injectible formulations for niche segments such as Osteoarthritis, Anti-Coagulants, Gynecology and Ophthalmology. It has earned a position of leadership in the country in injectibles manufacture.

Magal Associates Master planned, designed and engineered the complex with its buildings. Magal Associates is constantly involved in upgrading its operations and facilities to meet Current Good Manufacturing Practice (CGMP).